CXCL Gene Clusters Regulated by Enhancer-Mediated DNA Looping Alteration in Pancreatic Cancer Cells

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Pancreatic cancer is a highly lethal malignancy.
• Chemokines play a role in pancreatic cancer progression.
• Chromatin architecture influences gene cluster transcription, but its role in pancreatic cancer chemokine gene regulation is unknown.

Purpose of the Study:

• To investigate the chromatin-mediated regulatory mechanisms governing chemokine gene cluster transcription in pancreatic cancer.
• To identify specific DNA looping interactions and their impact on chemokine gene expression and tumor behavior.

Main Methods:

• Comparative analysis of chemokine gene expression in pancreatic cancer cells versus normal cells.
• Identification and characterization of enhancer elements and DNA looping structures using CRISPR-Cas9.
• Assessment of changes in gene expression and tumor malignancy following enhancer disruption.

Main Results:

• Eight C-X-C motif chemokine ligand (CXCL) genes were upregulated, while three were downregulated in pancreatic cancer cells.
• Four enhancer elements formed DNA loops regulating the upregulated CXCL genes.
• Another enhancer controlled a separate DNA loop for the downregulated CXCL genes.
• Disruption of enhancers altered DNA looping, CXCL gene cluster expression, and pancreatic cancer cell malignancy.

Conclusions:

• Enhancer-dependent DNA looping is a key regulatory mechanism for CXCL gene clusters in pancreatic cancer.
• Alterations in these DNA loops contribute to pancreatic cancer progression and malignancy.
• This study reveals novel insights into the epigenetic regulation of chemokine genes in pancreatic cancer.